US 10633381
KRas G12C inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 10633381 (KRas G12C inhibitors) held by Mirati Therapeutics, Inc. expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00